Syndax Pharmaceuticals Inc (SNDX)

Feb 21, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 6.7%Here's What Happened - MarketBeat

Feb 21, 2025

Feb 21, 2025

Should investors be concerned about SNDX’s high price-to-sales ratio? - US Post News

Feb 21, 2025

Feb 21, 2025

Syndax Pharmaceuticals (SNDX) Projected to Post Earnings on Tuesday - MarketBeat

Feb 21, 2025

Feb 20, 2025

Here's Why We're Watching Syndax Pharmaceuticals' (NASDAQ:SNDX) Cash Burn Situation - Yahoo Finance

Feb 20, 2025

Feb 20, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Feb 20, 2025

Feb 19, 2025

When (SNDX) Moves Investors should Listen - Stock Traders Daily

Feb 19, 2025

Feb 18, 2025

Syndax Pharmaceuticals' SWOT analysis: stock poised for growth with FDA approvals - Investing.com

Feb 18, 2025

Feb 17, 2025

Insider Selling: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Insider Sells 4,618 Shares of Stock - MarketBeat

Feb 17, 2025

Feb 17, 2025

Insider Selling: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CFO Sells 3,777 Shares of Stock - MarketBeat

Feb 17, 2025

Feb 16, 2025

Michael A. Metzger Sells 13,288 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock - MarketBeat

Feb 16, 2025

Feb 16, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Feb 16, 2025

Feb 15, 2025

Syndax pharmaceuticals CFO Keith Goldan sells $58,558 in stock - MSN

Feb 15, 2025

Feb 15, 2025

Don't Ignore The Insider Selling In Syndax Pharmaceuticals - Simply Wall St

Feb 15, 2025

Feb 14, 2025

abrdn plc Takes Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Feb 14, 2025

Feb 13, 2025

Syndax pharmaceuticals CFO sells $58,558 in stock - MSN

Feb 13, 2025

Feb 12, 2025

Syndax Pharmaceuticals CEO sells $206,017 in shares - MSN

Feb 12, 2025

Feb 12, 2025

Syndax pharmaceuticals CFO Keith Goldan sells $58,558 in stock By Investing.com - Investing.com Australia

Feb 12, 2025

Feb 12, 2025

Syndax pharmaceuticals CFO sells $58,558 in stock By Investing.com - Investing.com Nigeria

Feb 12, 2025

Feb 12, 2025

Syndax Pharmaceuticals CEO sells $206,017 in shares By Investing.com - Investing.com South Africa

Feb 12, 2025

Feb 12, 2025

Syndax Pharmaceuticals Executives Sell Shares for Tax Obligations - TradingView

Feb 12, 2025

Feb 11, 2025

Is Syndax Pharmaceuticals Inc (SNDX) positioned for future growth? - SETE News

Feb 11, 2025

Feb 11, 2025

2 ‘Strong Buy’ Growth Stocks Poised For 141% To 193% Gains, According To Wall Street - Barchart

Feb 11, 2025

Feb 11, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap UpShould You Buy? - MarketBeat

Feb 11, 2025

Feb 10, 2025

Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm - GlobeNewswire Inc.

Feb 10, 2025

Feb 08, 2025

Learn to Evaluate (SNDX) using the Charts - Stock Traders Daily

Feb 08, 2025

Feb 07, 2025

Syndax Pharmaceuticals Inc [SNDX] stock for 25,037 USD was acquired by Goldan Keith A. - Knox Daily

Feb 07, 2025

Feb 07, 2025

Syndax Pharmaceuticals Inc (SNDX) deserves deeper analysis - US Post News

Feb 07, 2025

Feb 06, 2025

Kura Oncology falls despite trial success; rival Syndax gains - Seeking Alpha

Feb 06, 2025

Feb 06, 2025

Can Syndax Pharmaceuticals Inc Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle

Feb 06, 2025

Feb 04, 2025

Syndax Expands Team: Strategic Stock Options Grant Signals Major Growth Phase - StockTitan

Feb 04, 2025

Feb 04, 2025

Ready to Jump After Recent Trade: Syndax Pharmaceuticals Inc (SNDX) - SETE News

Feb 04, 2025

Feb 04, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Yahoo Finance

Feb 04, 2025

Jan 30, 2025

Syndax Leadership Reveals Growth Strategy at Elite Healthcare Investment Forums - StockTitan

Jan 30, 2025

Jan 30, 2025

Syndax Announces Participation in February Investor Conferences - Yahoo Finance

Jan 30, 2025

Jan 28, 2025

(SNDX) Investment Analysis and Advice - Stock Traders Daily

Jan 28, 2025

Jan 23, 2025

Incyte and Syndax to scale Niktimvo production after FDA approval - BioProcess Insider

Jan 23, 2025